AAPL   317.94 (-0.10%)
MSFT   183.25 (+1.02%)
FB   225.09 (-0.16%)
GOOGL   1,433.52 (+1.08%)
AMZN   2,442.37 (+1.72%)
NVDA   355.02 (+4.58%)
CGC   17.37 (-20.03%)
BABA   207.39 (+3.96%)
MU   47.91 (+3.10%)
GE   6.57 (-3.10%)
TSLA   835.00 (+3.62%)
AMD   53.80 (+3.98%)
T   30.86 (-0.64%)
ACB   14.08 (-8.21%)
GILD   77.83 (+3.33%)
NFLX   419.73 (+1.52%)
BAC   24.12 (-2.98%)
BA   145.85 (-2.65%)
AAPL   317.94 (-0.10%)
MSFT   183.25 (+1.02%)
FB   225.09 (-0.16%)
GOOGL   1,433.52 (+1.08%)
AMZN   2,442.37 (+1.72%)
NVDA   355.02 (+4.58%)
CGC   17.37 (-20.03%)
BABA   207.39 (+3.96%)
MU   47.91 (+3.10%)
GE   6.57 (-3.10%)
TSLA   835.00 (+3.62%)
AMD   53.80 (+3.98%)
T   30.86 (-0.64%)
ACB   14.08 (-8.21%)
GILD   77.83 (+3.33%)
NFLX   419.73 (+1.52%)
BAC   24.12 (-2.98%)
BA   145.85 (-2.65%)
AAPL   317.94 (-0.10%)
MSFT   183.25 (+1.02%)
FB   225.09 (-0.16%)
GOOGL   1,433.52 (+1.08%)
AMZN   2,442.37 (+1.72%)
NVDA   355.02 (+4.58%)
CGC   17.37 (-20.03%)
BABA   207.39 (+3.96%)
MU   47.91 (+3.10%)
GE   6.57 (-3.10%)
TSLA   835.00 (+3.62%)
AMD   53.80 (+3.98%)
T   30.86 (-0.64%)
ACB   14.08 (-8.21%)
GILD   77.83 (+3.33%)
NFLX   419.73 (+1.52%)
BAC   24.12 (-2.98%)
BA   145.85 (-2.65%)
AAPL   317.94 (-0.10%)
MSFT   183.25 (+1.02%)
FB   225.09 (-0.16%)
GOOGL   1,433.52 (+1.08%)
AMZN   2,442.37 (+1.72%)
NVDA   355.02 (+4.58%)
CGC   17.37 (-20.03%)
BABA   207.39 (+3.96%)
MU   47.91 (+3.10%)
GE   6.57 (-3.10%)
TSLA   835.00 (+3.62%)
AMD   53.80 (+3.98%)
T   30.86 (-0.64%)
ACB   14.08 (-8.21%)
GILD   77.83 (+3.33%)
NFLX   419.73 (+1.52%)
BAC   24.12 (-2.98%)
BA   145.85 (-2.65%)
Log in

NYSE:RMEDRA Medical Systems Stock Price, Forecast & News

$0.52
+0.02 (+4.03 %)
(As of 05/29/2020 04:00 PM ET)
Add
Compare
Today's Range
$0.46
Now: $0.52
$0.52
50-Day Range
$0.48
MA: $0.93
$1.24
52-Week Range
$0.35
Now: $0.52
$3.70
Volume7.11 million shs
Average Volume1.03 million shs
Market Capitalization$7.17 million
P/E RatioN/A
Dividend YieldN/A
Beta1.48
Ra Medical Systems, Inc., a commercial-stage medical device company, develops, manufactures, and markets excimer lasers for use in the treatment of vascular and dermatological diseases. The company offers DABRA (destruction of arteriosclerotic blockages by laser radiation ablation), a minimally-invasive excimer laser and disposable catheter system that is used by physicians in the endovascular treatment of vascular blockages resulting from lower extremity vascular disease. It also provides Pharos, an excimer laser device that emits highly concentrated ultraviolet light used in the treatment of dermatological skin disorders. The company sells its products primarily through its direct sales force in the United States. Ra Medical Systems, Inc. was founded in 2002 and is headquartered in Carlsbad, California.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 3.1Community Rank: 2.1Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 1.3 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.30 out of 5 stars


Industry, Sector and Symbol

Industry Surgical & medical instruments
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone760-804-1648

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$7.20 million
Book Value$1.91 per share

Profitability

Net Income$-56,960,000.00
Net Margins-732.37%

Miscellaneous

Employees95
Market Cap$7.17 million
Next Earnings Date11/25/2020 (Estimated)
OptionableNot Optionable

Receive RMED News and Ratings via Email

Sign-up to receive the latest news and ratings for RMED and its competitors with MarketBeat's FREE daily newsletter.

RA Medical Systems (NYSE:RMED) Frequently Asked Questions

How has RA Medical Systems' stock been impacted by COVID-19 (Coronavirus)?

RA Medical Systems' stock was trading at $1.2563 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, RMED stock has decreased by 58.9% and is now trading at $0.5160. View which stocks have been most impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of RA Medical Systems?

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for RA Medical Systems in the last year. There are currently 3 hold ratings and 1 buy rating for the stock, resulting in a consensus recommendation of "Hold." View analyst ratings for RA Medical Systems.

When is RA Medical Systems' next earnings date?

RA Medical Systems is scheduled to release its next quarterly earnings announcement on Wednesday, November 25th 2020. View our earnings forecast for RA Medical Systems.

How were RA Medical Systems' earnings last quarter?

RA Medical Systems Inc (NYSE:RMED) announced its quarterly earnings data on Wednesday, May, 13th. The company reported ($0.56) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.34) by $0.22. The business earned $1.37 million during the quarter, compared to the consensus estimate of $1.51 million. RA Medical Systems had a negative net margin of 732.37% and a negative return on equity of 130.46%. View RA Medical Systems' earnings history.

What price target have analysts set for RMED?

4 equities research analysts have issued 12-month price targets for RA Medical Systems' shares. Their forecasts range from $1.00 to $3.00. On average, they expect RA Medical Systems' stock price to reach $1.75 in the next year. This suggests a possible upside of 239.1% from the stock's current price. View analysts' price targets for RA Medical Systems.

Has RA Medical Systems been receiving favorable news coverage?

News coverage about RMED stock has trended very negative on Friday, InfoTrie Sentiment reports. The research firm identifies negative and positive press coverage by reviewing more than six thousand news and blog sources. The firm ranks coverage of companies on a scale of negative five to positive five, with scores closest to five being the most favorable. RA Medical Systems earned a news sentiment score of -3.0 on InfoTrie's scale. They also gave media stories about the company a news buzz of 10.0 out of 10, indicating that recent press coverage is extremely likely to have an impact on the company's share price in the near future. View the latest news aboutRA Medical Systems.

Are investors shorting RA Medical Systems?

RA Medical Systems saw a increase in short interest during the month of May. As of May 15th, there was short interest totaling 196,700 shares, an increase of 108.1% from the April 30th total of 94,500 shares. Based on an average daily volume of 104,900 shares, the short-interest ratio is presently 1.9 days. Approximately 2.4% of the company's shares are short sold. View RA Medical Systems' Current Options Chain.

Who are some of RA Medical Systems' key competitors?

What other stocks do shareholders of RA Medical Systems own?

Based on aggregate information from My MarketBeat watchlists, some companies that other RA Medical Systems investors own include Corbus Pharmaceuticals (CRBP), Vaxart (VXRT), Amarin (AMRN), Co-Diagnostics (CODX), Inovio Pharmaceuticals (INO), Agile Therapeutics (AGRX), Nabriva Therapeutics (NBRV), VBI Vaccines (VBIV), vTv Therapeutics (VTVT) and Advanced Micro Devices (AMD).

Who are RA Medical Systems' key executives?

RA Medical Systems' management team includes the following people:
  • Mr. Dean Irwin, CEO, Chief Technology Officer & Chairman of Director (Age 56)
  • Mr. Jeffrey Jay Kraws, Pres (Age 55)
  • Ms. Melissa Burstein, Exec. VP & Director (Age 43)
  • Mr. Richard Heymann, Director of Corp. Strategy & Bus. Devel. (Age 64)
  • Mr. Andrew C. Jackson, Chief Financial Officer (Age 50)

When did RA Medical Systems IPO?

(RMED) raised $50 million in an IPO on Thursday, September 27th 2018. The company issued 3,300,000 shares at $14.00-$16.00 per share. Piper Jaffray and Cantor acted as the underwriters for the IPO and SunTrust Robinson Humphrey, Nomura and Maxim Group were co-managers.

What is RA Medical Systems' stock symbol?

RA Medical Systems trades on the New York Stock Exchange (NYSE) under the ticker symbol "RMED."

Who are RA Medical Systems' major shareholders?

RA Medical Systems' stock is owned by many different retail and institutional investors. Top institutional shareholders include Principal Financial Group Inc. (3.53%) and Bourne Lent Asset Management Inc. (1.53%). Company insiders that own RA Medical Systems stock include Andrew C Jackson, Dean Irwin, Jeffrey J Kraws, Jonathan Will Mcguire and Martin Burstein. View institutional ownership trends for RA Medical Systems.

Which major investors are selling RA Medical Systems stock?

RMED stock was sold by a variety of institutional investors in the last quarter, including Principal Financial Group Inc.. Company insiders that have sold RA Medical Systems company stock in the last year include Andrew C Jackson, Dean Irwin, Jeffrey J Kraws, and Martin Burstein. View insider buying and selling activity for RA Medical Systems.

Which major investors are buying RA Medical Systems stock?

RMED stock was acquired by a variety of institutional investors in the last quarter, including Bourne Lent Asset Management Inc.. View insider buying and selling activity for RA Medical Systems.

How do I buy shares of RA Medical Systems?

Shares of RMED can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is RA Medical Systems' stock price today?

One share of RMED stock can currently be purchased for approximately $0.52.

How big of a company is RA Medical Systems?

RA Medical Systems has a market capitalization of $7.17 million and generates $7.20 million in revenue each year. The company earns $-56,960,000.00 in net income (profit) each year or ($4.33) on an earnings per share basis. RA Medical Systems employs 95 workers across the globe.

What is RA Medical Systems' official website?

The official website for RA Medical Systems is www.ramed.com.

How can I contact RA Medical Systems?

RA Medical Systems' mailing address is 2070 Las Palmas Drive, Carlsbad CA, 92011. The company can be reached via phone at 760-804-1648 or via email at [email protected]

This page was last updated on 5/29/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.